TRDA - Entrada Therapeutics GAAP EPS of $1.02 revenue of $43.74M November, 07 2023 08:37 AM Entrada Therapeutics Inc. 2023-11-07 08:37:21 ET More on Entrada Therapeutics Seeking Alpha’s Quant Rating on Entrada Therapeutics Historical earnings data for Entrada Therapeutics Financial information for Entrada Therapeutics For further details see: Entrada Therapeutics GAAP EPS of $1.02, revenue of $43.74M